Please login to the form below

SEC

This page shows the latest SEC news and features for those working in and with pharma, biotech and healthcare.

‘Missing protein’ biotech Stoke raises $142m in IPO

In Stoke’s IPO prospectus filed with the Securities &Exchange Commission (SEC), the company says it will file for approval to start trials of STK-001 early in 2020 and will

Latest news

‘Missing protein’ biotech Stoke raises $142m in IPO

In Stoke’s IPO prospectus filed with the Securities &Exchange Commission (SEC), the company says it will file for approval to start trials of STK-001 early in 2020 and will
AZ preps new roxadustat filings, though data foxes investors

FibroGen’s sell-off seemed to relate to what some observers considered was cautious language in the company’s recent 10-Q filing with the Securities &Exchange Commission (SEC) on the
CAR-T player Autolus seeks $100m from follow-on financing

to raise additional capital in order to develop and commercialize our product candidates,” said Autolus in an filing with the US Securities &Exchange Commission (SEC).
AVEO warns EU approval of Fotivda could be at risk

Now, the US company says in a filing with the Securities &Exchange Commission (SEC) that the EMA will consider taking “regulatory action” if a new read-out from TIVO-3 due
Liver specialist Genfit files $120m IPO on Nasdaq

In an SEC filing, the French company says that in a phase 2b trial elafibranor “achieved resolution of NASH without worsening of fibrosis, which is the primary endpoint of our ongoing

More from news
Approximately 2 fully matching, plus 60 partially matching documents found.

Latest Intelligence

Creating a successful global compliance programme

The importance of effective compliance programmes was highlighted in the DOJ and SEC’s Resource Guide to the US Foreign Corrupt Practices Act, which describes in detail the hallmarks of a
Deal Watch January 2018

However, in the meantime the US Securities and Exchange Commission (SEC) has issued a lawsuit against some traders for insider trading based on a series of suspicious transactions that made about
US health reforms

In March, the Securities and Exchange Commission (SEC) only narrowly blocked this move.
Deal Watch - May 2017

A good example is Abbott’s acquisition of the diagnostics company Alere signed in February 2016. Two months later Abbott asked Alere to cancel the transaction because of a SEC inquiry ... into accounting issues at Alere and offered $30m to $50m
On the road with the millennial HCP

Yeah I'll put Andy on. Just hang on a sec, he's just sorting our next lift.”.

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest appointments

RSA announces three new UK hires

In 2009, de Luis moved to the UK with SEC Recruitment and spent three years focussing on the Spanish pharmaceutical market across a number of functional areas.
Scottish cabinet reshuffle sees Alex Neil made health secretary

Commenting on Twitter, Sturgeon said: “It has been a privilege to have been Health Sec[retary] - my thanks to all the wonderful people I have worked with.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

SALES ACCELERANT

We help companies to engage prim/sec care healthcare professionals more efficiently and effectively to drive sales growth.
SEC Pharma

Analysis, SEC can assist wherever you are looking to hire or work throughout the UK and Europe.

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Client Services Director- Flexible Working: Negotiable

Strategic Planner, Healthcare Advertising Agency: Salary TBC

Account Director – UK Office: Excellent salary and benefits

Account Manager – Healthcare advertising: Salary TBC

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Senior Medical Writer: Competitive salary plus benefits

Events Executive: DOE

Subscribe to our email news alerts

PMHub

Add my company

Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

Report: Customer experience, shaping digital healthcare: In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Encouraging signs in biomarker R&D: The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it: What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...